RAD
RADIOPHARM THERANOSTICS LIMITED
$0.0050
0.00%
Market cap
$24M
Turnover
$27,147
Last price
$0.0050
Day change
0.00%
Announcements
12
Range, past year
Open 0.035 · Low 0.004 · Now 0.005 · High 0.040
Open RAD in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
RAD momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
25/100
Wyckoff phase
Downtrend5d
Trend stage
Neutral
1 Day
+0.0%
1 Week
+0.0%
1 Month
-44.4%
1 Year
-86.1%
RSI
34
Avg daily range
20.3%
RADIOPHARM THERANOSTICS LIMITED scores 25 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Downtrend, where it has been for 5 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
What stands out
- Trend R² 0.91 — highly linear uptrend
Points to watch
- 60d drawdown -73.7%
- High volatility (ATR 20.3%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsRAD announcements
Recent price-sensitive releases.
- 2026-08-28 Appendix 4E and Preliminary Final Report Preliminary Final Report
- 2026-08-26 RAD Doses First Patient in Second Cohort of BetaBart (RV-01) Progress Report
- 2026-08-20 RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial Progress Report
- 2026-08-17 RAD to meet with US FDA to align on RAD 101 Phase 3 Trial Progress Report
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-24 Reinstatement to Quotation Reinstatement to Official Quotation
- 2026-07-24 RAD completes A$12.5 M placement and launches A$6 M SPP Placement | Issued Capital - Other | Security Purchase Plan
More Health Care stocks
Most traded in the same sector.